Community Voices

Humanizing Bipolar Disorder: An Interview With David Swain, MBA
Posted on: Mar 25, 2019

Individuals living with mental health diagnoses are often marginalized by society, and stigmatization and discrimination may form a barrier to their recovery and social integration. There are a lot of strategies to help combat the stigma associated with mental illness, including sharing information about mental illness; talking openly about mental health; using person-first, non-discriminatory language;…

Meet The Treatment Team: Peer Support Specialist
Posted on: Mar 18, 2019

In this interview, Dwayne Mayes sits down with Nicole Meade, PhD from the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical Affairs Team, to discuss the role a peer support specialist may play on the treatment team of individuals living with mental illness. Mr. Mayes is the Program Director of the Recovery Network & Peer…

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia
Posted on: Mar 4, 2019

Schizophrenia affects roughly 1.1% percent of the U.S. population (3.4 million adults), with direct annual costs estimated at $47 billion. Schizophrenia is defined as a chronic, relapsing, and disabling disorder, which may include symptomology such as hallucinations, delusions, disoriented-thinking, affective flattening, apathy, and social withdrawal. Relapse in schizophrenia can occur when patients don’t adhere to…

Trauma Informed Care: Relevance In Primary Care & Mental Health Settings
Posted on: Feb 18, 2019

In this interview, Dr. Bahr describes trauma informed care and why health care providers should be aware of and implement trauma informed practices. She also shares her perspective on the importance of trauma informed care from the health plan perspective. Terry A. Bahr, PhD, CPC, currently serves as the Recovery & Resiliency Manager at Behavioral…

HRV & Biofeedback For Treatment Of Psychological Conditions: What Is It & How Does It Work?
Posted on: Jan 14, 2019

Heart rate variability (HRV) has been understood for some time as a measure of sympathetic and parasympathetic activity in the body. HRV biofeedback is a technique by which the change in the time intervals between adjacent heartbeats is measured while cardiorespiratory feedback training is conducted. This technique has promise as a non-invasive biomarker for certain…

Meet The Treatment Team: Psychiatric Pharmacist
Posted on: Jan 7, 2019

In this interview, Kelly Lee, PharmD, MAS, BCPP, FCCP, sits down with Monica Kim, PharmD, MBA from the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical Affairs Team to discuss the role a psychiatric pharmacist may play on the treatment team of individuals with mental illness. Dr. Lee is a Professor of Clinical Pharmacy and…

Treatment Resistant Depression: Changes In Attitudes & Approaches
Posted on: Jan 7, 2019

In this interview, Dr. Scott Aaronson sits down with Gerard Zitnik, PhD, Medical Science Liaison from the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical Affairs Team. He discusses treatment resistant depression: what it is, how it may be different from major depressive disorder, associated symptomology and quality of life measures, and how the psychiatric…

Practical Application Of Tools For Measurement-Based Care: Suicide Risk Screening
Posted on: Dec 24, 2018

In this series of interviews, Sloan Manning, MD, discusses a variety of screening tools that may be used in primary care (or mental health) settings to screen for mental health symptoms and associated risks, and measure response and change in symptoms over time. For this installment, Dr. Manning focuses on a variety of screening tools…

Q&A: Tackling Behavioral Health Provider Shortages: Health Plan Strategies From Access To Engagement
Posted on: Nov 7, 2018

During this question and answer session, William Wood and Deb Adler respond to unanswered questions from the PsychU webinar, “Tackling Behavioral Health Provider Shortages: Health Plan Strategies From Access To Engagement” which took place on November 7, 2018. William Wood, MD, PhD, is the Former Managing Medical Director at Anthem and Deb Adler, MS, CPQH,…

The Use Of Psychopharmacology In Treatment For Depression In Pregnant & Nursing Women
Posted on: Nov 5, 2018

In this interview, Jennifer Payne, MD, discusses common misconceptions surrounding the use of psychotropic medications to treat major depression or bipolar disorder in pregnant women or those who are nursing. She discusses perceptions of medication use during pregnancy, and common stigmatizing beliefs held by practitioners and the public at large related to psychiatric treatment when…

Update On The Role Of Gut Microbiota Modulation For The Treatment & Prevention Of Mood & Anxiety
Live Program | March 27, 2019 6:00 pm to 8:00 pm CT @ Lenexa, KS

Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis
Live Program | April 10, 2019 6:30 pm to 8:30 pm CT @ Chicago, IL

Recognizing & Responding To Inadequately Treated Major Depressive Disorder
Live Program | April 11, 2019 6:00 pm to 8:00 pm PT @ Wauwatosa, WI

Psychoneuroimmunology: Immune System & Neuroinflammation Basics
Live Program | April 11, 2019 6:30 pm to 8:30 pm ET @ Hastings-On-Hudson, NY

Community Voices

Not a member? Sign up for free!

Humanizing Bipolar Disorder: An Interview With David Swain, MBA
Posted on: Mar 25, 2019

Meet The Treatment Team: Peer Support Specialist
Posted on: Mar 18, 2019

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia
Posted on: Mar 4, 2019

Trauma Informed Care: Relevance In Primary Care & Mental Health Settings
Posted on: Feb 18, 2019

HRV & Biofeedback For Treatment Of Psychological Conditions: What Is It & How Does It Work?
Posted on: Jan 14, 2019

Meet The Treatment Team: Psychiatric Pharmacist
Posted on: Jan 7, 2019

Treatment Resistant Depression: Changes In Attitudes & Approaches
Posted on: Jan 7, 2019

Practical Application Of Tools For Measurement-Based Care: Suicide Risk Screening
Posted on: Dec 24, 2018

Q&A: Tackling Behavioral Health Provider Shortages: Health Plan Strategies From Access To Engagement
Posted on: Nov 7, 2018

The Use Of Psychopharmacology In Treatment For Depression In Pregnant & Nursing Women
Posted on: Nov 5, 2018

Update On The Role Of Gut Microbiota Modulation For The Treatment & Prevention Of Mood & Anxiety Live Program | March 27, 2019 6:00 pm to 8:00 pm CT @ Lenexa, KS

Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis Live Program | April 10, 2019 6:30 pm to 8:30 pm CT @ Chicago, IL

Recognizing & Responding To Inadequately Treated Major Depressive Disorder Live Program | April 11, 2019 6:00 pm to 8:00 pm PT @ Wauwatosa, WI

Psychoneuroimmunology: Immune System & Neuroinflammation Basics Live Program | April 11, 2019 6:30 pm to 8:30 pm ET @ Hastings-On-Hudson, NY

Community Voices

Not a member? Sign up for free!

Humanizing Bipolar Disorder: An Interview With David Swain, MBA Posted on: Mar 25, 2019

Meet The Treatment Team: Peer Support Specialist Posted on: Mar 18, 2019

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia Posted on: Mar 4, 2019

Trauma Informed Care: Relevance In Primary Care & Mental Health Settings Posted on: Feb 18, 2019

HRV & Biofeedback For Treatment Of Psychological Conditions: What Is It & How Does It Work? Posted on: Jan 14, 2019

Meet The Treatment Team: Psychiatric Pharmacist Posted on: Jan 7, 2019

Treatment Resistant Depression: Changes In Attitudes & Approaches Posted on: Jan 7, 2019

Practical Application Of Tools For Measurement-Based Care: Suicide Risk Screening Posted on: Dec 24, 2018

Q&A: Tackling Behavioral Health Provider Shortages: Health Plan Strategies From Access To Engagement Posted on: Nov 7, 2018

The Use Of Psychopharmacology In Treatment For Depression In Pregnant & Nursing Women Posted on: Nov 5, 2018

Now Leaving PsychU

This link will take you outside of the PsychU community website.

Now Leaving PsychU

This link will take you to a website outside of PsychU.org.

You are attempting to log out of PsychU, please confirm.

Update On The Role Of Gut Microbiota Modulation For The Treatment & Prevention Of Mood & Anxiety
Live Program | March 27, 2019 6:00 pm to 8:00 pm CT @ Lenexa, KS

Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis
Live Program | April 10, 2019 6:30 pm to 8:30 pm CT @ Chicago, IL

Recognizing & Responding To Inadequately Treated Major Depressive Disorder
Live Program | April 11, 2019 6:00 pm to 8:00 pm PT @ Wauwatosa, WI

Psychoneuroimmunology: Immune System & Neuroinflammation Basics
Live Program | April 11, 2019 6:30 pm to 8:30 pm ET @ Hastings-On-Hudson, NY

Humanizing Bipolar Disorder: An Interview With David Swain, MBA
Posted on: Mar 25, 2019

Meet The Treatment Team: Peer Support Specialist
Posted on: Mar 18, 2019

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia
Posted on: Mar 4, 2019

Trauma Informed Care: Relevance In Primary Care & Mental Health Settings
Posted on: Feb 18, 2019

HRV & Biofeedback For Treatment Of Psychological Conditions: What Is It & How Does It Work?
Posted on: Jan 14, 2019

Meet The Treatment Team: Psychiatric Pharmacist
Posted on: Jan 7, 2019

Treatment Resistant Depression: Changes In Attitudes & Approaches
Posted on: Jan 7, 2019

Practical Application Of Tools For Measurement-Based Care: Suicide Risk Screening
Posted on: Dec 24, 2018

Q&A: Tackling Behavioral Health Provider Shortages: Health Plan Strategies From Access To Engagement
Posted on: Nov 7, 2018

The Use Of Psychopharmacology In Treatment For Depression In Pregnant & Nursing Women
Posted on: Nov 5, 2018